Blood Glucose Monitoring Point-Of-Care Market: Bright Growth Prospects

https://seekingalpha.com/article/4323733-bloo...-prospects






"SMBG demand may grow in developing regions
While CGM offers considerable advantages over SMBG, CGM devices are generally more costly than SMBG devices and hence they are relatively less popular in low-and-middle income countries. In Asia-Pacific, the SMBG market accounts for more than 93% of blood glucose meter sales in the region and this is likely to remain so in the near future, given that many developing countries lack a national framework for diabetes management and only one country, Thailand, covers more than 80% of diabetes expenditure. In most Asian countries, government funds or national insurance covers just a fraction of diabetes expenditure (if at all), except for China, Japan, Singapore, and Thailand. Consequently, medical supplies and devices such as glucometers are often paid out of pocket in most Asian countries.

Nevertheless, the growth potential is enormous. 79% of people with diabetes live in low-and middle-income countries (equal to more than 300 million people, nearly the entire population of the United States of America)."